Charles Rhyee Analyst PerformanceManaging Director at TD CowenCharles Rhyee is a stock analyst at TD Cowen focused in the medical sector, covering 23 publicly traded companies. Over the past year, Charles Rhyee has issued 42 stock ratings, including buy, hold, and sell recommendations. While full access to Charles Rhyee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Charles Rhyee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings67 Last 11 YearsBuy Recommendations69.35% 43 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution62RatingsDistribution of strong buy, buy, hold, and sell ratings by Charles Rhyee.RatingPercentageCount Strong Buy0.0%0 ratings Buy69.4%43 ratings Hold27.4%17 ratings Sell3.2%2 ratingsOut of 62 total stock ratings issued by Charles Rhyee at TD Cowen, the majority (69.4%) have been Buy recommendations, followed by 27.4% Hold and 3.2% Sell.Best & Worst CallsBest Call0000.0%NHAug 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TDOCJul 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ47.8% of companies on NASDAQ11 companiesNYSE47.8% of companies on NYSE11 companiesOTCMKTS4.3% of companies on OTCMKTS1 companyCharles Rhyee, an analyst at TD Cowen, currently covers 23 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies82.6%Manufacturing1 company4.3%Computer and Technology1 company4.3%Miscellaneous1 company4.3%Business Services1 company4.3%Charles Rhyee of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES9 companies39.1%MEDICAL INFO SYS3 companies13.0%MED/DENTAL - SUPP2 companies8.7%MED - OUTP/HM CRE1 company4.3%MED - BIOMED/GENE1 company4.3%MED INSTRUMENTS1 company4.3%MED - HMO1 company4.3%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company4.3%DATA PROCESSING & PREPARATION1 company4.3%INTERNET SOFTWARE1 company4.3%HOLDING & OTHER INVESTMENT OFFICES1 company4.3%MANAGEMENT SERVICES1 company4.3% Charles Rhyee's Ratings History at TD Cowen Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGDRXGoodRx5/11/2026Boost Price Target$2.90$4.00Buy$0.0000.00% ROICVSCVS Health5/11/2026Boost Price Target$91.53$110.00Buy$0.0000.00% ROICVSCVS Health5/11/2026Boost Price Target$90.50$110.00Buy$0.0000.00% ROIAMWLAmerican Well5/6/2026Boost Price Target$7.42$8.00Hold$0.0000.00% ROIBTSGBrightSpring Health Services5/4/2026Boost Price Target$53.66$65.00Buy$0.0000.00% ROICAHCardinal Health5/1/2026Boost Price Target$194.06$255.00Buy$0.0000.00% ROIOPCHOption Care Health5/1/2026Lower Price Target$20.15$23.00Hold$0.0000.00% ROICVSCVS Health3/13/2026Reiterated Rating$76.64Buy$0.0000.00% ROIFTREFortrea3/9/2026Upgrade$9.61$15.00Buy$0.0000.00% ROIIQVIQVIA3/9/2026Upgrade$174.56$213.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. VEEVVeeva Systems3/5/2026Lower Price Target$192.65$300.00Buy$0.0000.00% ROITDOCTeladoc Health2/26/2026Lower Price Target$5.29$6.00Hold$0.0000.00% ROICRLCharles River Laboratories International2/20/2026Lower Price Target$165.65$235.00Buy$0.0000.00% ROIMEDPMedpace2/18/2026Upgrade$428.18$419.00Hold$0.0000.00% ROIICLRIcon2/18/2026Upgrade$88.62$120.00Buy$0.0000.00% ROIICLRIcon2/12/2026Reiterated Rating$80.84Hold$0.0000.00% ROICAHCardinal Health2/11/2026Boost Price Target$220.82$251.00Buy$0.0000.00% ROICICigna Group2/9/2026Boost Price Target$294.00$338.00Buy$0.0000.00% ROIMCKMcKesson2/5/2026Boost Price Target$819.58$1,012.00Buy$0.0000.00% ROICAHCardinal Health1/27/2026Reiterated Rating$210.83Buy$0.0000.00% ROIOPCHOption Care Health1/27/2026Reiterated Rating$36.21Hold$0.0000.00% ROIIQVIQVIA1/22/2026Boost Price Target$242.16$245.00Hold$0.0000.00% ROIICLRIcon1/22/2026Boost Price Target$188.91$183.00Hold$0.0000.00% ROIFTREFortrea1/22/2026Boost Price Target$17.63$15.00Hold$0.0000.00% ROICRLCharles River Laboratories International1/22/2026Reiterated Rating$224.94Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$46.00Buy$0.0000.00% ROICICigna Group12/15/2025Set Price Target$274.70$333.00$0.0000.00% ROICVSCVS Health12/10/2025Boost Price Target$80.17$105.00Buy$0.0000.00% ROIGDRXGoodRx11/10/2025Lower Price Target$3.02$6.00Buy$0.0000.00% ROICRLCharles River Laboratories International11/10/2025Lower Price Target$169.38$197.00Buy$0.0000.00% ROICORCencora11/10/2025Boost Price Target$362.89$400.00Buy$0.0000.00% ROICICigna Group11/4/2025Lower Price Target$261.09$333.00Buy$0.0000.00% ROIIQVIQVIA11/3/2025Downgrade$216.43$215.00Hold$0.0000.00% ROICVSCVS Health11/3/2025Boost Price Target$78.14$100.00Buy$0.0000.00% ROICAHCardinal Health11/3/2025Boost Price Target$190.22$225.00Buy$0.0000.00% ROIOPCHOption Care Health11/3/2025Lower Price Target$26.38$27.00Hold$0.0000.00% ROIICLRIcon10/24/2025Lower Price Target$175.71$172.00Hold$0.0000.00% ROIMEDPMedpace10/24/2025Boost Price Target$603.22$462.00Sell$0.0000.00% ROIVEEVVeeva Systems10/7/2025Upgrade$299.84$380.00Buy$0.0000.00% ROIOPCHOption Care Health10/2/2025Initiated Coverage$27.24$30.00Hold$0.0000.00% ROIBefore you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listingMCKMcKesson9/24/2025Boost Price Target$760.40$864.00Buy$0.0000.00% ROIMEDPMedpace7/23/2025Reiterated Rating$477.73$366.00Sell$0.0000.00% ROIICLRIcon4/14/2025Downgrade$144.04$157.00Hold$000.0000.00% ROIMEDPMedpace4/14/2025Downgrade$297.72$328.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
